title: Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck: In Regard to Inohara et al.
authors.affiliation: Malabar Cancer Center, Kannur, Kerala, India.
authors.forename: Sanudev Sadanandan Vadakke
authors.initials: SS
authors.lastname: Puthiyottil
authors.affiliation: Malabar Cancer Center, Kannur, Kerala, India.
authors.forename: Tapesh
authors.initials: T
authors.lastname: Bhattacharyya
authors.affiliation: Malabar Cancer Center, Kannur, Kerala, India.
authors.forename: Kiran
authors.initials: K
authors.lastname: Purushothaman
authors.affiliation: Malabar Cancer Center, Kannur, Kerala, India.
authors.forename: Geetha
authors.initials: G
authors.lastname: Muttath
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods*; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D008297:Male; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D043823:Taxoids